These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Regulation of differentiation in transformed erythroid cells. Rifkind RA, Marks PA. Blood Cells; 1978; 4(1-2):189-206. PubMed ID: 371697 [Abstract] [Full Text] [Related]
3. Cytochemical characteristics of leukopoietic differentiation in murine erythroleukemic (Friend) cells. Fioritoni G, Bertolini L, Torlontano G, Revoltella R. Cancer Res; 1980 Mar; 40(3):866-72. PubMed ID: 6937242 [Abstract] [Full Text] [Related]
4. Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the Friend system. Tsiftsoglou AS, Wong W. Anticancer Res; 1985 Mar; 5(1):81-99. PubMed ID: 3888045 [Abstract] [Full Text] [Related]
5. The role of erythropoietin in the production of principal erythrocyte proteins other than hemoglobin during terminal erythroid differentiation. Koury MJ, Bondurant MC, Mueller TJ. J Cell Physiol; 1986 Feb; 126(2):259-65. PubMed ID: 3080441 [Abstract] [Full Text] [Related]
15. [Commitment to erythroid differentiation and globin gene expression in the absence of heme accumulation in Friend leukemia cells]. Gambari R. Boll Soc Ital Biol Sper; 1983 May 30; 59(5):631-7. PubMed ID: 6882562 [Abstract] [Full Text] [Related]
16. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity. Murate T, Yamashita K, Ohashi H, Kagami Y, Tsushita K, Kinoshita T, Hotta T, Saito H, Yoshida S, Mori KJ. Exp Hematol; 1993 Jan 30; 21(1):169-76. PubMed ID: 8417953 [Abstract] [Full Text] [Related]
17. [Molecular basis of erythroid cell differentiation and its implication in clinical medicine (author's transl)]. Terada M. Tanpakushitsu Kakusan Koso; 1974 May 30; 19(5):379-87. PubMed ID: 4607913 [No Abstract] [Full Text] [Related]
18. Erythropoietin control of terminal erythroid differentiation: maintenance of cell viability, production of hemoglobin, and development of the erythrocyte membrane. Koury MJ, Bondurant MC, Atkinson JB. Blood Cells; 1987 May 30; 13(1-2):217-26. PubMed ID: 3478108 [Abstract] [Full Text] [Related]
19. Splenic erythroblasts in anemia-inducing Friend disease: a source of cells for studies of erythropoietin-mediated differentiation. Koury MJ, Sawyer ST, Bondurant MC. J Cell Physiol; 1984 Dec 30; 121(3):526-32. PubMed ID: 6501430 [Abstract] [Full Text] [Related]
20. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage. Kelley LL, Hicks GG, Hsieh FF, Prasher JM, Green WF, Miller MD, Eide EJ, Ruley HE. Oncogene; 1998 Sep 03; 17(9):1119-30. PubMed ID: 9764822 [Abstract] [Full Text] [Related] Page: [Next] [New Search]